{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:28:49Z","timestamp":1792222129745,"version":"4.4.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ebiom.2019.03.077","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T09:19:49Z","timestamp":1554196789000},"page":"295-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1"],"prefix":"10.1016","volume":"43","author":[{"given":"Jan","family":"Kristoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana L.","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana M.","family":"Garcia-Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengli","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sluis-Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phalguni","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Rinaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5501-503X","authenticated-orcid":false,"given":"Robbie B.","family":"Mailliard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2019.03.077_bb0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cell.2013.09.044","article-title":"An integrated overview of HIV-1 latency","volume":"155","author":"Ruelas","year":"2013","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2019.03.077_bb0010","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tim.2015.01.013","article-title":"Towards an HIV-1 cure: measuring the latent reservoir","volume":"23","author":"Bruner","year":"2015","journal-title":"Trends Microbiol"},{"issue":"7408","key":"10.1016\/j.ebiom.2019.03.077_bb0015","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/487439a","article-title":"HIV: Shock and kill","volume":"487","author":"Deeks","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ebiom.2019.03.077_bb0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1172\/JCI80566","article-title":"HIV-specific CD8(+) T cells and HIV eradication","volume":"126","author":"Jones","year":"2016","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.ebiom.2019.03.077_bb0025","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri1417","article-title":"HIV and SIV CTL escape: implications for vaccine design","volume":"4","author":"Goulder","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2019.03.077_bb0030","article-title":"Antigen processing and presentation in HIV infection","author":"Boucau","year":"2018","journal-title":"Mol Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2019.03.077_bb0035","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.4049\/jimmunol.1300373","article-title":"Selective induction of CTL helper rather than killer activity by natural epitope variants promotes dendritic cell-mediated HIV-1 dissemination","volume":"191","author":"Mailliard","year":"2013","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2019.03.077_bb0040","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00473-16","article-title":"Effective cytotoxic T lymphocyte targeting of persistent HIV-1 during antiretroviral therapy requires priming of naive CD8+ T cells","volume":"7","author":"Smith","year":"2016","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.ebiom.2019.03.077_bb0045","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.chom.2017.03.008","article-title":"Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes, which shape the proviral landscape","volume":"21","author":"Pollack","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.ebiom.2019.03.077_bb0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm.3489","article-title":"New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo","volume":"20","author":"Bullen","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2019.03.077_bb0055","doi-asserted-by":"crossref","first-page":"30749","DOI":"10.1038\/srep30749","article-title":"The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function","volume":"6","author":"Clutton","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2019.03.077_bb0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/COC.0b013e3181a31920","article-title":"Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma","volume":"33","author":"Lam","year":"2010","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2019.03.077_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.leukres.2010.06.001","article-title":"Differentiation therapy in poor risk myeloid malignancies: results of a dose finding study of the combination bryostatin-1 and GM-CSF","volume":"35","author":"Smith","year":"2011","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.ebiom.2019.03.077_bb0070","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10637-010-9557-5","article-title":"Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study","volume":"30","author":"Morgan","year":"2012","journal-title":"Invest New Drugs"},{"issue":"4","key":"10.1016\/j.ebiom.2019.03.077_bb0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10637-006-6452-1","article-title":"A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma","volume":"24","author":"Ajani","year":"2006","journal-title":"Invest New Drugs"},{"issue":"9","key":"10.1016\/j.ebiom.2019.03.077_bb0080","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/QAD.0000000000001064","article-title":"Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy","volume":"30","author":"Gutierrez","year":"2016","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.ebiom.2019.03.077_bb0085","doi-asserted-by":"crossref","first-page":"e1004287","DOI":"10.1371\/journal.ppat.1004287","article-title":"Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes","volume":"10","author":"Jones","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2019.03.077_bb0090","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.phrs.2018.10.023","article-title":"T cell toxicity of HIV latency reversing agents","volume":"139","author":"Zhao","year":"2019","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.ebiom.2019.03.077_bb0095","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02166-16","article-title":"Toll-like receptor 7 agonist GS-9620 induces HIV expression and HIV-specific immunity in cells from HIV-infected individuals on suppressive antiretroviral therapy","volume":"91","author":"Tsai","year":"2017","journal-title":"J Virol"},{"issue":"7632","key":"10.1016\/j.ebiom.2019.03.077_bb0100","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nature20583","article-title":"Ad26\/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys","volume":"540","author":"Borducchi","year":"2016","journal-title":"Nature"},{"issue":"7734","key":"10.1016\/j.ebiom.2019.03.077_bb0105","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1038\/s41586-018-0721-y","article-title":"Publisher correction: antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys","volume":"564","author":"Borducchi","year":"2018","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ebiom.2019.03.077_bb0110","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/cid\/cix201","article-title":"Short-course toll-like receptor 9 agonist treatment impacts innate immunity and plasma viremia in individuals with human immunodeficiency virus infection","volume":"64","author":"Vibholm","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"5919","key":"10.1016\/j.ebiom.2019.03.077_bb0115","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1165706","article-title":"The challenge of finding a cure for HIV infection","volume":"323","author":"Richman","year":"2009","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ebiom.2019.03.077_bb0120","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/CVI.00221-07","article-title":"Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals","volume":"15","author":"Connolly","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"166","key":"10.1016\/j.ebiom.2019.03.077_bb0125","doi-asserted-by":"crossref","first-page":"166ra2","DOI":"10.1126\/scitranslmed.3004682","article-title":"A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication","volume":"5","author":"Garcia","year":"2013","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.ebiom.2019.03.077_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004752","article-title":"Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity","volume":"11","author":"Brezar","year":"2015","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.ebiom.2019.03.077_bb0135","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/eji.201344433","article-title":"Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load","volume":"44","author":"Levy","year":"2014","journal-title":"Eur J Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2019.03.077_bb0140","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/infdis\/jiv582","article-title":"Therapeutic vaccination with dendritic cells loaded with autologous HIV type 1-infected apoptotic cells","volume":"213","author":"Macatangay","year":"2016","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2019.03.077_bb0145","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4049\/jimmunol.1401832","article-title":"CD40L induces functional tunneling nanotube networks exclusively in dendritic cells programmed by mediators of type 1 immunity","volume":"194","author":"Zaccard","year":"2015","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2019.03.077_bb0150","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.184.2.747","article-title":"Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation","volume":"184","author":"Cella","year":"1996","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.ebiom.2019.03.077_bb0155","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nm.4347","article-title":"Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4(+) T cells","volume":"23","author":"Sanyal","year":"2017","journal-title":"Nat Med"},{"issue":"17","key":"10.1016\/j.ebiom.2019.03.077_bb0160","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1158\/0008-5472.CAN-04-1261","article-title":"Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity","volume":"64","author":"Mailliard","year":"2004","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.ebiom.2019.03.077_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003834","article-title":"An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients","volume":"9","author":"Spina","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2019.03.077_bb0170","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/ncomms1948","article-title":"The CD4(+) T-cell help signal is transmitted from APC to CD8(+) T-cells via CD27-CD70 interactions","volume":"3","author":"Feau","year":"2012","journal-title":"Nat Commun"},{"issue":"6684","key":"10.1016\/j.ebiom.2019.03.077_bb0175","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/30996","article-title":"Help for cytotoxic-T-cell responses is mediated by CD40 signalling","volume":"393","author":"Bennett","year":"1998","journal-title":"Nature"},{"issue":"6684","key":"10.1016\/j.ebiom.2019.03.077_bb0180","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/30989","article-title":"A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell","volume":"393","author":"Ridge","year":"1998","journal-title":"Nature"},{"issue":"6684","key":"10.1016\/j.ebiom.2019.03.077_bb0185","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/31002","article-title":"T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ebiom.2019.03.077_bb0190","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1128\/jvi.70.9.6044-6053.1996","article-title":"CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef","volume":"70","author":"Chen","year":"1996","journal-title":"J Virol"},{"issue":"13","key":"10.1016\/j.ebiom.2019.03.077_bb0195","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/00002030-200209060-00006","article-title":"In patients on prolonged HAART, a significant pool of HIV infected CD4 T cells are HIV-specific","volume":"16","author":"Demoustier","year":"2002","journal-title":"AIDS"},{"issue":"6884","key":"10.1016\/j.ebiom.2019.03.077_bb0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4+ T cells","volume":"417","author":"Douek","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ebiom.2019.03.077_bb0205","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/jac\/dkl049","article-title":"Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease","volume":"57","author":"Stone","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.ebiom.2019.03.077_bb0210","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.4049\/jimmunol.1700851","article-title":"Cytomegalovirus (CMV) epitope-specific CD4(+) T cells are inflated in HIV(+) CMV(+) subjects","volume":"199","author":"Abana","year":"2017","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2019.03.077_bb0215","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/infdis\/jiu093","article-title":"Heterogeneity of CD4+ and CD8+ T-cell responses to cytomegalovirus in HIV-infected and HIV-uninfected men who have sex with men","volume":"210","author":"Li","year":"2014","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2019.03.077_bb0220","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4049\/jimmunol.174.2.619","article-title":"Peripheral \"CD8 tuning\" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo","volume":"174","author":"Maile","year":"2005","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2019.03.077_bb0225","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.4156","article-title":"Defective proviruses rapidly accumulate during acute HIV-1 infection","volume":"22","author":"Bruner","year":"2016","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ebiom.2019.03.077_bb0230","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1172\/JCI97555","article-title":"Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells","volume":"128","author":"Huang","year":"2018","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.ebiom.2019.03.077_bb0235","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1080\/21505594.2017.1356535","article-title":"Dendritic cells maturated by co-culturing with HIV-1 latently infected Jurkat T cells or stimulating with AIDS-associated pathogens secrete TNF-alpha to reactivate HIV-1 from latency","volume":"8","author":"Ren","year":"2017","journal-title":"Virulence"},{"issue":"3","key":"10.1016\/j.ebiom.2019.03.077_bb0240","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/gt.2014.117","article-title":"Vpx-containing dendritic cell vaccine induces CTLs and reactivates latent HIV-1 in vitro","volume":"22","author":"Norton","year":"2015","journal-title":"Gene Ther"},{"issue":"11","key":"10.1016\/j.ebiom.2019.03.077_bb0245","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.4049\/jimmunol.181.11.7713","article-title":"An in vitro system to model the establishment and reactivation of HIV-1 latency","volume":"181","author":"Marini","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2019.03.077_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003259","article-title":"Dendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytes","volume":"9","author":"van der Sluis","year":"2013","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.ebiom.2019.03.077_bb0255","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med"},{"issue":"14","key":"10.1016\/j.ebiom.2019.03.077_bb0260","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1128\/JVI.00070-06","article-title":"Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo","volume":"80","author":"Brenchley","year":"2006","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.ebiom.2019.03.077_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000646","article-title":"Autocrine production of beta-chemokines protects CMV-specific CD4 T cells from HIV infection","volume":"5","author":"Casazza","year":"2009","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.ebiom.2019.03.077_bb0270","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1006\/viro.2000.0697","article-title":"Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects","volume":"279","author":"Komanduri","year":"2001","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.ebiom.2019.03.077_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008886","article-title":"Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease","volume":"5","author":"Naeger","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2019.03.077_bb0280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11904-016-0297-9","article-title":"Partners in crime: the role of CMV in immune Dysregulation and clinical outcome during HIV infection","volume":"13","author":"Freeman","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"11","key":"10.1016\/j.ebiom.2019.03.077_bb0285","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/cid\/ciw612","article-title":"Asymptomatic CMV replication during early human immunodeficiency virus (HIV) infection is associated with lower CD4\/CD8 ratio during HIV treatment","volume":"63","author":"Smith","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ebiom.2019.03.077_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165774","article-title":"CMV+ Serostatus associates negatively with CD4:CD8 ratio normalization in controlled HIV-infected patients on cART","volume":"11","author":"Poizot-Martin","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ebiom.2019.03.077_bb0295","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/QAI.0000000000000936","article-title":"Brief report: effect of CMV and HIV transcription on CD57 and PD-1 T-cell expression during suppressive ART","volume":"72","author":"Dan","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.ebiom.2019.03.077_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006202","article-title":"Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction","volume":"13","author":"Maidji","year":"2017","journal-title":"PLoS Pathog"},{"issue":"15","key":"10.1016\/j.ebiom.2019.03.077_bb0305","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/QAD.0000000000001579","article-title":"Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals","volume":"31","author":"Gianella","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2019.03.077_bb0310","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1089\/aid.2017.0145","article-title":"Cytomegalovirus and HIV persistence: pouring gas on the fire","volume":"33","author":"Christensen-Quick","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"8","key":"10.1016\/j.ebiom.2019.03.077_bb0315","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1128\/JVI.02638-15","article-title":"Replication of human Herpesviruses is associated with higher HIV DNA levels during antiretroviral therapy started at early phases of HIV infection","volume":"90","author":"Gianella","year":"2016","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.ebiom.2019.03.077_bb0320","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/infdis\/jiu424","article-title":"Cytomegalovirus upregulates expression of CCR5 in central memory cord blood mononuclear cells, which may facilitate in utero HIV type 1 transmission","volume":"211","author":"Johnson","year":"2015","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2019.03.077_bb0325","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/jvi.64.6.2932-2940.1990","article-title":"Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1","volume":"64","author":"Barry","year":"1990","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.ebiom.2019.03.077_bb0330","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/13550289809113494","article-title":"Cytomegalovirus and human herpesvirus-6 trans-activate the HIV-1 long terminal repeat via multiple response regions in human fetal astrocytes","volume":"4","author":"McCarthy","year":"1998","journal-title":"J Neurovirol"},{"issue":"7","key":"10.1016\/j.ebiom.2019.03.077_bb0335","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1128\/jvi.71.7.5692-5695.1997","article-title":"Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-kappaB-binding sites of the interleukin-8 gene","volume":"71","author":"Murayama","year":"1997","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2019.03.077_bb0340","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12977-016-0284-7","article-title":"HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-kappaB","volume":"13","author":"Saleh","year":"2016","journal-title":"Retrovirology"},{"issue":"6","key":"10.1016\/j.ebiom.2019.03.077_bb0345","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jis777","article-title":"Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA","volume":"207","author":"Gianella","year":"2013","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.ebiom.2019.03.077_bb0350","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1128\/JVI.00831-14","article-title":"Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment","volume":"88","author":"Gianella","year":"2014","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.ebiom.2019.03.077_bb0355","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/infdis\/jiv092","article-title":"Longitudinal genetic characterization reveals that cell proliferation maintains a persistent HIV type 1 DNA Pool during effective HIV therapy","volume":"212","author":"von Stockenstrom","year":"2015","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2019.03.077_bb0360","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1128\/JVI.01985-12","article-title":"An increasing proportion of monotypic HIV-1 DNA sequences during antiretroviral treatment suggests proliferation of HIV-infected cells","volume":"87","author":"Wagner","year":"2013","journal-title":"J Virol"},{"issue":"6196","key":"10.1016\/j.ebiom.2019.03.077_bb0365","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.1256304","article-title":"HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection","volume":"345","author":"Wagner","year":"2014","journal-title":"Science"},{"issue":"6193","key":"10.1016\/j.ebiom.2019.03.077_bb0370","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.1254194","article-title":"HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells","volume":"345","author":"Maldarelli","year":"2014","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ebiom.2019.03.077_bb0375","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.cell.2015.01.020","article-title":"HIV-1 integration landscape during latent and active infection","volume":"160","author":"Cohn","year":"2015","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2019.03.077_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006283","article-title":"Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir","volume":"13","author":"Bui","year":"2017","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.ebiom.2019.03.077_bb0385","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1084\/jem.20170193","article-title":"Proliferation of latently infected CD4(+) T cells carrying replication-competent HIV-1: potential role in latent reservoir dynamics","volume":"214","author":"Hosmane","year":"2017","journal-title":"J Exp Med"},{"issue":"49","key":"10.1016\/j.ebiom.2019.03.077_bb0390","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1617789113","article-title":"Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA","volume":"113","author":"Lorenzi","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.ebiom.2019.03.077_bb0395","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/infdis\/jix265","article-title":"Human immunodeficiency virus type 1 Persistence following systemic chemotherapy for malignancy","volume":"216","author":"Henrich","year":"2017","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2019.03.077_bb0400","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm.3445","article-title":"HIV-1 persistence in CD4+ T cells with stem cell-like properties","volume":"20","author":"Buzon","year":"2014","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.ebiom.2019.03.077_bb0405","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.4049\/jimmunol.1402090","article-title":"Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency","volume":"194","author":"Schmueck-Henneresse","year":"2015","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2019.03.077_bb0410","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4049\/jimmunol.171.5.2366","article-title":"Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function","volume":"171","author":"Mailliard","year":"2003","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2019.03.077_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005677","article-title":"Human Galectin-9 is a potent mediator of HIV transcription and reactivation","volume":"12","author":"Abdel-Mohsen","year":"2016","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.ebiom.2019.03.077_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005545","article-title":"A subset of latency-reversing agents expose HIV-infected resting CD4+ T-cells to recognition by cytotoxic T-lymphocytes","volume":"12","author":"Jones","year":"2016","journal-title":"PLoS Pathog"},{"issue":"15","key":"10.1016\/j.ebiom.2019.03.077_bb0425","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1097\/QAD.0000000000001201","article-title":"Standard vaccines increase HIV-1 transcription during antiretroviral therapy","volume":"30","author":"Yek","year":"2016","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.ebiom.2019.03.077_bb0430","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0000000000001829","article-title":"Influenza vaccination can broadly activate the HIV reservoir during antiretroviral therapy","volume":"79","author":"Christensen-Quick","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.ebiom.2019.03.077_bb0435","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1084\/jem.20121932","article-title":"Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production","volume":"210","author":"Perreau","year":"2013","journal-title":"J Exp Med"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419302221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419302221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:54:52Z","timestamp":1762455292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419302221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":87,"alternative-id":["S2352396419302221"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.03.077","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735447396.793563719","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.03.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}